Damora Therapeutics (DMRA) Q3 2026 Earnings

5AugConfirmed
Q4 2025
Q2 2026
Next
-2.36
-1.7
-1.05
-0.39

Details

Expected EPS
-0.435603
Actual EPS
N/A
Surprise EPS
0.44
Surprise Percent
+100%

Description

Damora Therapeutics (DMRA) will report earnings of for Q3 2026 on August 05, 2026.

0 Comments

Share your thoughts